A vial of the Moderna Covid-19 vaccine.Ted S. Warren (AP) Moderna's fourth-quarter profit tumbled 70% as Covid-19 vaccine sales fell and the drugmaker caught up on a royalty payment.Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its Spikevax coronavirus preventive shots.
#people #united-states #development #researchers #federal-government #massachusetts #improvement #fourth-quarter #wall-street-journal #million-doses
[
add
]
[
|
|
...
]